印度即将在其南部的钦格尔普特地区进行首次大规模的麻风菌苗(从犰狳中制取)临床试验.菌苗在WHO赞助下研究,由英国的Burroughs公司提供.印度医学研究委员会(ICMR)会长Ramalingaswami说,ICMR的Jalma麻风研究所将负责计划和实施该项试验,预期对30万健康接触者进行接种.他们将通过对接种组和非接种组的比较来评价菌苗的预防效果.并对单独接种 India is about to conduct its first large-scale clinical trials of leprosy bacterins (made from armadillo) in the southern district of Chinggulpt. The vaccine is being studied under the auspices of WHO and is being supplied by Burroughs in the United Kingdom. The Indian Medical Research Council (ICMR) President Ramalingaswami said ICMR’s Jalma leprosy institute will plan and implement the trial, which is expected to vaccinate 300,000 health contacts who will evaluate the efficacy of the vaccine by comparing the vaccinated and non-vaccinated groups Prevention effect and vaccination alone